The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

Immune checkpoint inhibitors (ICIs), a major type of cancer immunotherapy, don't do much for hospitalized cancer patients, ...

A real-world Danish registry study showed a significant increased relative risk, but small absolute risk, for stroke and ...

Background Cardiovascular disease (CVD) remains a significant public health challenge in China. This study aimed to project ...

A 17-year analysis found sex-based differences in the prevalence and treatment of patients with ST-segment elevation MI with nonobstructive coronary arteries, but the mortality risk remains similar.

Atherosclerotic cardiovascular disease is a major health concern worldwide and requires effective preventive measures. Lp(a) (lipoprotein [a]) has recently garnered attention as an independent risk ...

A new biological patch, designed from heart cells grown in the laboratory, could bring a glimmer of hope in the treatment of ...

BACKGROUND: The optimal coronary stenting technique for true left main bifurcation lesions is uncertain. EBC MAIN (European ...

The researchers hope that their findings will help improve treatment guidelines and ... global longitudinal strain in patients with myocardial infarction and preserved ejection fraction - a ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...

Hudson Regional Hospital’s Cardiac Catheterization Lab has earned New Jersey state Department of Health approval for STEMI (ST-segment Elevation Myocardial Infarction), allowing its ...